Wexford Capital’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,000
Closed -$178 139
2022
Q2
$178 Buy
+25,000
New +$178 0.01% 167